DERMAL SOURCE – Trademark Portfolio

Entity Type: 03

DERMAL SOURCE holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ZONE 1, ZONE 2, and VASOCAINE. The owner is based in Portland, OR.

2319 NE Glisan St.

Portland, OR 97232

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ZONE 2
ZONE 2
Registered 2004
ZONE 1
ZONE 1
Registered 2004
VASOCAINE
VASOCAINE
Registered 2004
SJ3
SJ3
Cancelled 2004

Trademark Classifications

DERMAL SOURCE's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does DERMAL SOURCE have?

DERMAL SOURCE has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 2 cancelled.

What trademark classes does DERMAL SOURCE file in?

DERMAL SOURCE files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are DERMAL SOURCE's most well-known trademarks?

DERMAL SOURCE's registered trademark portfolio includes well-known marks such as ZONE 1, ZONE 2, and VASOCAINE. These are among 3 currently registered trademarks in the portfolio.

What is DERMAL SOURCE's trademark registration success rate?

DERMAL SOURCE has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.